Wire Stories
-
606SOSLAB to Unveil 3D Solid-State LiDAR ‘ML-X’ Installed in Automotive Lamps at CES 2023
LAS VEGAS–(BUSINESS WIRE)–#3DSolidstateLiDAR—SOSLAB (CEO: Ji Seong Jeong) announced today the release of its next-generation 3D solid-state LiDAR �ML-X� for automotive lamps at...
-
449270 Free Spins and a $2,000 Blackjack Jackpot at Juicy Stakes
Take a look at what�s on offer online this week SYDNEY–(BUSINESS WIRE)–New Year�s Eve has been and gone, but the party is...
-
423Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen�s Hybrozyme� Technology
DAEJEON, South Korea–(BUSINESS WIRE)–#ALTB4—Alteogen Inc. (KOSDAQ:196170) announced today that the company has entered into an exclusive license agreement with Sandoz AG. Under...
-
591Legend Biotech Announces Acceptance of Its New Drug Application for Ciltacabtagene Autoleucel (Cilta-Cel) in China
SOMERSET, N.J.–(BUSINESS WIRE)–$LEGN–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening...
-
417$2,000 New Year Tournament at Juicy Stakes Casino
Take a look at what�s on offer online this week SYDNEY–(BUSINESS WIRE)–New Year, same old Juicy Stakes Casino. Your favourite online casino...
-
449CORRECTING and REPLACING XPENG Announces Vehicle Delivery Results for December and Fourth Quarter 2022
11,292 vehicles delivered in December 2022 22,204 vehicles delivered in Q4 2022 120,757 vehicles delivered cumulatively for the full year of 2022...
-
415
XPENG Announces Vehicle Delivery Results for December and Fourth Quarter 2022
11,292 vehicles delivered in December 2022 22,204 vehicles delivered in Q4 2022 120,757 vehicles delivered cumulatively for the full year of 2022...
-
472Pony.ai Approved to Deploy Fully Driverless L4 Autonomous Vehicles in Beijing
Among the first batch of two companies to receive a driverless testing permit Pony.ai is also testing fully driverless autonomous vehicles in...
-
477BeiGene Announces Acceptance of 12th Regulatory Submission in China for PD-1 Inhibitor Tislelizumab
Submission seeks marketing authorization for first-line treatment of unresectable or metastatic hepatocellular carcinoma CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ:...
-
425
Qu�bec Nickel Corp. Announces Closing of the Second Tranche of Its Previously Announced Private Placement
VANCOUVER, British Columbia–(BUSINESS WIRE)–Qu�bec Nickel Corp. (CSE: QNI) (�Qu�bec Nickel Corp.� or the �Company�) is pleased to announce that it has completed...
